Genetics

CYP2C19 genotyping may aid antiplatelet prescribing

(HealthDay)—Genotyping may provide some clinical benefit in prescribing antiplatelet therapies for patients undergoing percutaneous coronary intervention (PCI), according to a study published in the Aug. 25 issue of the ...

Medications

Gout drug repurposed to fight heart disease

Colchicine reduces the risk of major cardiovascular events in patients with chronic coronary disease, according to results of the LoDoCo2 trial presented in a Hot Line session today at ESC Congress 2020.

Diseases, Conditions, Syndromes

Hospitalization rates for AMI dropped during early COVID-19

(HealthDay)—During the early COVID-19 period, there was a decrease in hospitalization rates for acute myocardial infarction (AMI), according to a brief report published online Aug. 7 in JAMA Cardiology.

page 31 from 40